Anuh Pharma Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: ANUHPHR BSE: 506260

₹87.40

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #94 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Anuh Pharma Limited (this stock)	876	19.8	11.9%	4.9%	1.72%	72	65	50

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹868 Cr

EV / EBITDA

12.1x

EV / Sales

1.11x

Market cap / Sales

1.12x

Earnings yield

5.05%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 197 Cr, up 3.7% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 11 Cr, up 37.6% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	194	17	11	₹1.1400
March 31, 2026	202	16	12	₹1.1700
Dec. 31, 2025	197	18	13	₹1.3400
Sept. 30, 2025	186	10	8	₹0.7600
June 30, 2025	186	11	8	₹1.6600
March 31, 2025	198	17	12	₹2.4900
Dec. 31, 2024	160	13	10	₹2.0600
Sept. 30, 2024	166	18	15	₹3.0000
June 30, 2024	138	12	10	₹1.9000
March 31, 2024	164	20	15	₹3.0600
Dec. 31, 2023	172	25	19	₹3.8100
Sept. 30, 2023	150	18	14	₹2.7600
June 30, 2023	161	15	12	₹2.3500

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	197	201	201	187	190	200	160	169	142	167	176	152	165
Operating revenue	194	202	197	186	186	198	160	166	138	164	172	150	161
Other income	3	-1	4	1	3	1	1	3	4	3	4	2	3
Operating expenses	178	182	180	174	176	179	145	149	127	145	148	132	148
Operating profit	16	20	17	12	10	19	15	17	11	19	24	18	14
Operating profit margin	8.4%	9.8%	8.5%	6.4%	5.5%	9.4%	9.3%	10.2%	7.7%	11.7%	13.9%	12.0%	8.7%
Depreciation	2	3	3	3	3	3	2	2	2	2	2	2	2
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	17	16	18	10	11	17	13	18	12	20	25	18	15
Tax	6	4	4	2	3	5	3	3	3	4	6	4	4
Net profit	11	—	13	8	8	12	10	15	10	15	19	14	12
EPS	1.14	1.17	1.34	0.76	1.66	2.49	2.06	3.00	1.90	3.06	3.81	2.76	2.35
Net profit (TTM)	—	—	42	39	46	47	50	59	58	60	54	45	41
EPS (TTM)	4.41	4.93	6.25	6.97	9.21	9.45	10.02	11.77	11.53	11.98	10.84	8.89	8.11

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	772	54	41
March 31, 2025	662	61	47

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	13.4%	12.0%	779^†	671^†	659^†	534^†	492^†	442^†	311^†	325^†	249^†	210^†
Operating revenue	13.5%	12.3%	772	662	647^†	527^†	487^†	432^†	307^†	321^†	241^†	206^†
Other income	—	—	7^†	9^†	12^†	6^†	5^†	11^†	4^†	5^†	8^†	4^†
Operating expenses	—	—	713^†	601^†	572^†	476^†	439^†	387^†	284^†	291^†	—	183^†
Operating profit	4.7%	5.7%	59^†	61^†	75^†	51^†	47^†	45^†	23^†	30^†	—	23^†
Operating profit margin	—	—	7.6%^†	9.2%^†	11.6%^†	9.7%^†	9.7%^†	10.3%^†	7.4%^†	9.2%^†	—	11.2%^†
Depreciation	—	—	11^†	9^†	9^†	10^†	12^†	15^†	7^†	2^†	—	2^†
Interest	—	—	0^†	1^†	0^†	0^†	1^†	1^†	1^†	0^†	0^†	0^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	4.5%	7.1%	54	61	78^†	47^†	39^†	39^†	19^†	32^†	26^†	25^†
Tax	—	—	13^†	14^†	18^†	11^†	9^†	10^†	5^†	9^†	7^†	8^†
Net profit	4.3%	7.6%	41	47	60^†	36^†	31^†	28^†	14^†	23^†	19^†	18^†
EPS	-11.9%	-11.3%	4.93^†	9.45^†	11.98^†	7.22^†	6.11^†	9.00^†	5.70^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	7.6%^†	9.2%^†	11.6%^†	9.7%^†	9.7%^†	10.3%^†	7.4%^†	9.2%^†	—	11.2%^†
EBIT margin	7.1%^†	9.3%^†	12.2%^†	9.0%^†	8.3%^†	9.3%^†	6.5%^†	10.2%^†	10.7%^†	12.2%^†
PBT margin	7.0%	9.2%	12.1%^†	9.0%^†	8.0%^†	8.9%^†	6.2%^†	10.1%^†	10.7%^†	12.2%^†
Net margin	5.3%	7.2%	9.3%^†	6.9%^†	6.3%^†	6.6%^†	4.7%^†	7.3%^†	7.8%^†	8.5%^†
Interest coverage	115.80x^†	99.51x^†	222.46x^†	218.35x^†	30.74x^†	26.80x^†	25.18x^†	190.60x^†	634.38x^†	564.09x^†
Dividend payout	30.4%^†	0.0%^†	0.0%^†	0.0%^†	0.0%^†	0.0%^†	0.0%^†	—	—	—
Earnings retention	69.6%^†	100.0%^†	100.0%^†	100.0%^†	100.0%^†	100.0%^†	100.0%^†	—	—	—
Current ratio	2.22x	2.11x	—	—	—	—	—	—	—	—
Quick ratio	1.50x	1.69x	—	—	—	—	—	—	—	—
Debt to equity	0.00x	0.03x	—	—	—	—	—	—	—	—
Return on equity	11.7%	14.5%	—	—	—	—	—	—	—	—
Return on assets	7.4%	9.3%	—	—	—	—	—	—	—	—
Return on capital employed	15.4%^†	18.8%^†	—	—	—	—	—	—	—	—
Asset turnover	1.38x	1.31x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	-3	18	-26	8	-11
March 31, 2025	37	-20	-5	20	17

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	557	352	302	0	0	451	203	8	48	148
March 31, 2025	507	326	301	10	0	376	179	20	50	74

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.